PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Wednesday-Thursday, April 20–21. If you were not able to join us live, some sessions have been recorded and are available below.

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences



  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session


Beyond the SSRI: Treating and Managing Major Depression

Jeffrey Rado, MD, MPH, FAPA


What happens when your patient does not respond to a SSRI?  What happens when your patient does not respond to treatment? This session will review how to manage these more challenging cases of depression that are all too common in primary care settings.

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern Feinberg School of Medicine, Chicago, IL

9:10–10:10am ET    CME/CE Accredited Session



PCPs can play an integral role in identifying anemia of chronic kidney disease (CKD) as well as in treating or referring patients with this complication. However, many PCPs are unaware of the disease burden, screening guidelines, and pathophysiology of anemia of CKD. Join this session to increase your awareness of the effect of anemia of CKD, to strengthen your ability to detect anemia of CKD, and to confidently discuss various treatment options.

Rajeev Raghavan, MD

Program Director, Internal Medicine, HCA Houston Healthcare, Professor, University of Houston, College of Medicine, Adjunct Faculty, Baylor College of Medicine, Houston, TX

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine

Supported by GlaxoSmithKline

10:20–11:05am ET    Non-CME Industry Theater


The Changing Treatment Landscape for Uncontrolled Asthma

Neil Skolnik, MD | Nanette Alexander, DNP, APRN,ANP-BC, FAANP


This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Neil Skolnik, MD

Neil Skolnik, MD

Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Nanette Alexander, DNP, APRN,ANP-BC, FAANP

Sponsored by GlaxoSmithKline

10:20–11:05am ET    Non-CME Industry Theater


Clinical Insights in VTE: Treatment and Reduction in the Risk of Recurrent DVT/PE

James Neuenschwander, MD, FACEP


This lecture will discuss the Treatment and Reduction in the Risk of Recurrent DVT/PE, Whether Initiated in the Inpatient or Outpatient Setting.

James Neuenschwander, MD, FACEP

Genesis Healthcare Systems/Ohio State University Medical Center

Sponsored by Janssen Pharmaceuticals, Inc.

11:15am–12:15pm ET    CME/CE Accredited Session

Infectious Disease

New Recommendations for Pneumococcal Immunizations: Taking Action, Protecting Patients 

Robert H. Hopkins, Jr., MD, MACP, FAAP | Rachel Caskey, MD, MAPP


The CDC Advisory Committee on Immunization Practices (ACIP) has completely revised the recommendations for pneumococcal immunization in adults for 2022. The change was made possible by the approval of 2 new conjugate vaccines that cover pneumococcal serotypes that significantly contribute to the burden of invasive pneumococcal disease. This is important because some individuals, including older adults or those with certain chronic medical conditions or immunocompromising conditions, are at increased risk for pneumococcal disease and its serious, sometimes life-threatening complications.

Robert H. Hopkins, Jr., MD, MACP, FAAP

Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AZ

Rachel Caskey, MD, MAPP

Associate Professor of Pediatrics and Internal Medicine, Chief of Academic Internal Medicine, University of Illinois at Chicago, Chicago, IL

Supported by Merck & Co. Inc.

12:25–1:25pm ET    CME/CE Accredited Session

Urgent Care

Common Urgent Care Cases and Navigating Pitfalls for PCPs

Lawrence Herman, DMSc, MPA, PA-C, DFAAPA


Join Lawrence Herman, DMSc, MPA, PA-C, DFAAPA, with over 20-years’ experience in urgent care, emergency medicine, and expert witness consultation, as he discusses four common urgent care presentations for primary care clinicians. He’ll also review pertinent positives and negatives associated with potential red flags to avoid malpractice, all without overtesting or slowing throughput.

Lawrence Herman, DMSc, MPA, PA-C, DFAAPA

Adjunct Professor, Doctor of Medical Science Program, University of Lynchburg, Lynchburg, Virginia, President, Palantir Healthcare, LLC, Boiling Springs, SC

1:35–2:20pm ET    Non-CME Industry Theater


Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO


  • Understand the causes and prevalence of chronic low back pain.
  • Differentiate inflammatory back pain (IBP) from mechanical back pain.
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.

Christopher Parker, DO

Sponsored by AbbVie Inc.

1:35–2:20pm ET    Non-CME Industry Theater


Clinical Considerations in Stroke or Transient Ischemic Attack

Ted Okerson, MD, FACP, FACE


  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population.
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial.

Ted Okerson, MD, FACP, FACE

Sponsored by AstraZeneca

2:30–3:30pm ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Panel Discussion (April 2022)

Daniel A. Solomon, MD | Laila Woc-Colburn, MD


This pandemic requires communication among specialists and primary care clinicians. In this COVID-19 panel, expert faculty will team up to discuss the most pressing and frequently asked questions about the disease and its complications.

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine,, Harvard Medical School, Boston, MA

Laila Woc-Colburn, MD

Associate Professor, Division of Infectious Diseases Emory University School of Medicine, Atlanta, GA

3:40–4:40pm ET    CME/CE Accredited Session


Cardiology Updates: What’s New with Valvular Heart Disease

Ty J. Gluckman, MD, FACC, FAHA


Join Dr. Ty Gluckman for a comprehensive review of the latest vavular heart disease guidelines.

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

4:50–5:35pm ET    Non-CME Industry Theater


Rare Eosinophilic Diseases of High Clinical Burden - EGPA & HES: How Primary Care can Help Spot the Zebra

Mili Shum, MD | Neil Skolnik, MD


Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, and hypereosinophilic syndrome (HES) are rare eosinophilic diseases of high consequence for patients, necessitating multi-specialty care.   The prolonged patient journey and high clinical burden often entails repeat primary care provider (PCP) evaluation. This educational program will review key facets of the EGPA and HES disease states with a focus on the pivotal role PCPs can have to help shorten the patient journey to proper diagnosis and care.

Mili Shum, MD

Assistant Professor of Medicine, Adjunct Professor of Pediatrics, University of Utah Health,, Salt Lake City, Utah

Neil Skolnik, MD

Neil Skolnik, MD

Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Sponsored by GlaxoSmithKline

8–11:30am ET    CME/CE Accredited Session


Strategies for Effective Pain Management in Clinical Practice

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP


The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine , Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo , Chief, Pain Medicine and Professor of Oncology , Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

11:40am–12:25pm ET    Non-CME Industry Theater

Infectious Disease

A Scientifically Designed Topical Treatment for Toenail Onychomycosis

Leon Kircik, MD


This session will provide an overview of onychomycosis including causative agents as well as the role mail physiology plays in effectiveness of treatments.  The role of both topical and oral products will be examined as well as presentation on the role of JUBLIA (Efinaconazole) Topical Solution 10% for the treatment of onychomycosis.


Leon Kircik, MD

Clinical Professor of Dermatology, Icahn School of Medicine at Mount Sinai, New York,NY, Indiana University Medical Center, Indianapolis, IN, Medical Director, Physicians Skin Care, PLLC Louisville, KY, DermResearch, PLLC Louisville, KY, Skin Sciences, PLLC Louisville, KY

Dr. Kircik is a Board Certified Dermatologist who graduated with AOA Honors from State University of New York at the Health Sciences Center at Brooklyn after completing his undergraduate work with Phi Beta Kappa at New York University. He completed a Mohs Micrographic Surgery and Cutaneous Oncology Fellowship under the auspices of Dr. Frederick Mohs at the University of Wisconsin after completing his dermatology residency at State University of New York in Buffalo., , He currently teaches as Associate Clinical Professor of Dermatology at Indiana University Medical Center in Indianapolis, IN, as well as Clinical Professor at Icahn School of Medicine at Mount Sinai Medical Center in New York City. Dr. Kircik is also the Medical Director of DermResearch, PLLC, Physicians Skin Care, PLLC and Skin Sciences, PLLC in Louisville, Kentucky. He has been the principal investigator of numerous clinical trials for psoriasis, acne, rosacea, atopic dermatitis, skin cancers, and actinic keratosis, just to name a few., , Dr. Kircik is an author of many scientific articles, abstracts and posters. He has lectured extensively nationally and internationally on all aspects of dermatologic conditions. In addition, he also serves on the advisory boards of several pharmaceutical companies as a consultant. He is on the editorial board of Journal of Drugs in Dermatology, Practical Dermatology, The Journal of Clinical & Aesthetic Dermatology, and Case Report in Clinical Pathology. He volunteers for multiple local and national medical society committees.

Sponsored by Bausch Health, US. LLC

11:40am–12:25pm ET    Non-CME Industry Theater


How Do You Choose the Next Oral Therapy for T2D?

Eugenio Angueira, MD, FACE


Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information. 

Eugenio Angueira, MD, FACE

Endocrinology Physician, Miami Endocrine Associates, Program Director, Endocrinology, Larkin Community Hospital, Clinical Assistant Professor, Nova Southeastern University, Clinical Assistant Professor, Lake Eries College of Osteopathic Medicine, Miami, FL

Sponsored by Novo Nordisk

12:35–1:35pm ET    CME/CE Accredited Session


What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration

Richard S. Isaacson, MD | Charles Vega, MD, FAAFP


Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on.

This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.

Richard S. Isaacson, MD

Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by Eisai

1:45–2:45pm ET    CME/CE Accredited Session

Infectious Disease

Expanding HPV Cancer Prevention: You Can Make a Difference

Kenneth A. Alexander, MD, PhD | Anna R. Giuliano, PhD


The epidemiology of human papillomavirus (HPV)-related cancers is changing. New cases of HPV-related oropharyngeal cancer in men now outnumber cases of cervical cancer in women. Prevention of HPV-related cancers is a public health priority. In this session, expert faculty will discuss how HPV-related disease can be prevented and even eliminated.

Kenneth A. Alexander, MD, PhD

Professor of Clinical Sciences, University of Central Florida College of Medicine, Chief, Division of Infectious Diseases, Nemours Children’s Hospital, Orlando, Florida

Anna R. Giuliano, PhD

Clinical Research Professor, Dorothea Bennett Memorial, American Cancer Society, Director, Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida

Supported by Merck & Co. Inc.

2:55–3:40pm ET    Non-CME Industry Theater


A Clinician’s Perspective on Managing Patients with Asthma

Monica Kraft, MD


Asthma is a significant public health concern in the US, making its diagnosis and management in clinical practice critically important, especially with recent increasing trends in prevalence and morbidity. With the help of engaging case-studies, this session will include discussions on the identification, diagnostic workup, and effective management of asthma. It will also review the assessment of symptom control and severity in patients with asthma.

Monica Kraft, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

3:50–4:50pm ET    CME/CE Accredited Session


Cases in Diabetes: Expert Panel Discussion

Tina K. Thethi, MD, MPH | Jose J. Perez, MD, FASN


Diabetes management is challenging, and the ever-changing management guidelines and pharmacologic options add to this complexity. Join this panel discussion, led by a primary care clinician, endocrinologist, and nephrologist as they review best practices in diabetes management with a focus on new updates and practical strategies to incorporate into your practice.

Tina K. Thethi, MD, MPH

Associate Investigator, AdventHealth, Translational Research Institute, Endocrinologist, AdventHealth, Diabetes Institute, Orlando, FL

Jose J. Perez, MD, FASN

Associate Professor, Nephrology Service Chief, Ben Taub General Hospital, Harris Health System, Section of Nephrology, Department of Medicine, Baylor College of Medicine

5–5:45pm ET    Non-CME Industry Theater


The Impact and Management of Moderate-to-Severe Atopic Dermatitis in Appropriate Patients

Michael J. Payette, MD, MBA, FAAD


Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate patients and a treatment option that may help them.

Michael J. Payette, MD, MBA, FAAD

Founding Partner, Central Connecticut Dermatology, Cromwell, CT, Investigator, CCD Research, Cromwell, CT, Associate Clinical Professor, Department of Dermatology, University of Connecticut, Farmington, Connecticut

Sponsored by Sanofi and Regeneron